@文章{info:doi/10.2196/35926，作者=" abantes, Ana M和Meshesha, Lidia Z和E Blevins, Claire和Battle, Cynthia L和Lindsay, Clifford和Marsh, Eliza和Feltus, Sage和Buman, Matthew和Agu, Emmanuel和Stein, Michael"，标题="酒精治疗患者的智能手机体育活动应用程序:单手臂可行性试验"，期刊="JMIR Form Res"，年="2022"，月="10"，日="19"，卷="6"，数="10"，页="e35926"，关键词="酒精使用障碍;澳元;身体活动;智能手机应用;Fitbit;可行性研究;背景:酒精使用障碍(AUD)是世界范围内一个重大的公共健康问题。在美国，酒精消费是导致死亡的主要原因，对个人和社会都有重大的负面影响。治疗后复发是常见的，辅助干预方法在早期恢复期间改善酒精预后仍然是关键。以增加身体活动(PA)为重点的干预可能改善AUD的治疗结果。 Given the ubiquity of smartphones and activity trackers, integrating this technology into a mobile app may be a feasible, acceptable, and scalable approach for increasing PA in individuals with AUD. Objective: This study aims to test the Fit{\&}Sober app developed for patients with AUD. The goals of the app were to facilitate self-monitoring of PA engagement and daily mood and alcohol cravings, increase awareness of immediate benefits of PA on mood and cravings, encourage setting and adjusting PA goals, provide resources and increase knowledge for increasing PA, and serve as a resource for alcohol relapse prevention strategies. Methods: To preliminarily test the Fit{\&}Sober app, we conducted an open pilot trial of patients with AUD in early recovery (N=22; 13/22, 59{\%} women; mean age 43.6, SD 11.6 years). At the time of hospital admission, participants drank 72{\%} of the days in the last 3 months, averaging 9 drinks per drinking day. The extent to which the Fit{\&}Sober app was feasible and acceptable among patients with AUD during early recovery was examined. Changes in alcohol consumption, PA, anxiety, depression, alcohol craving, and quality of life were also examined after 12 weeks of app use. Results: Participants reported high levels of satisfaction with the Fit{\&}Sober app. App metadata suggested that participants were still using the app approximately 2.5 days per week by the end of the intervention. Pre-post analyses revealed small-to-moderate effects on increase in PA, from a mean of 5784 (SD 2511) steps per day at baseline to 7236 (SD 3130) steps per day at 12 weeks (Cohen d=0.35). Moderate-to-large effects were observed for increases in percentage of abstinent days (Cohen d=2.17) and quality of life (Cohen d=0.58) as well as decreases in anxiety (Cohen d=−0.71) and depression symptoms (Cohen d=−0.58). Conclusions: The Fit{\&}Sober app is an acceptable and feasible approach for increasing PA in patients with AUD during early recovery. A future randomized controlled trial is necessary to determine the efficacy of the Fit{\&}Sober app for long-term maintenance of PA, ancillary mental health, and alcohol outcomes. If the efficacy of the Fit{\&}Sober app could be established, patients with AUD would have a valuable adjunct to traditional alcohol treatment that can be delivered in any setting and at any time, thereby improving the overall health and well-being of this population. Trial Registration: ClinicalTrials.gov NCT02958280; https://www.clinicaltrials.gov/ct2/show/NCT02958280 ", issn="2561-326X", doi="10.2196/35926", url="https://formative.www.mybigtv.com/2022/10/e35926", url="https://doi.org/10.2196/35926", url="http://www.ncbi.nlm.nih.gov/pubmed/36260381" }